NCT00992303 Collecting Tissue Samples From Patients With Cancer Undergoing Radiation Therapy and Healthy Participants
| NCT ID | NCT00992303 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Texas Southwestern Medical Center |
| Condition | Unspecified Adult Solid Tumor, Protocol Specific |
| Study Type | OBSERVATIONAL |
| Enrollment | 10,000 participants |
| Start Date | 2009-09 |
| Primary Completion | 2029-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10,000 participants in total. It began in 2009-09 with a primary completion date of 2029-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
RATIONALE: Collecting and storing samples of tissue from patients with cancer to test in the laboratory may help the study of cancer in the future. PURPOSE: This research study is collecting tissue samples from patients with cancer undergoing radiation therapy. Healthy participants will also be allowed on the trial so their samples can be used in comparison to patients with malignancy
Eligibility Criteria
DISEASE CHARACTERISTICS: * Pathologically-proven diagnosis of malignancy * Planning treatment with radiation therapy PATIENT CHARACTERISTICS: * Able to perform follow-up visits * Is a patient of the University of Texas Southwestern Medical Center physicians PRIOR CONCURRENT THERAPY: * See Disease Characteristics * Participation in other clinical trials is allowed * Other prior or concurrent therapy for cancer, such as surgery and/or chemotherapy, is allowed. Criteria for eligibility: * Able to provide written informed consent * Age greater than 18 years old * Males and Females are eligible * Any ethnicity is eligible Criteria for ineligibility: -Patients not available for follow-up/future contact
Contact & Investigator
Robert Timmerman, MD
PRINCIPAL INVESTIGATOR
University of Texas Southwestern Medical Center - Dallas
Frequently Asked Questions
Who can join the NCT00992303 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Unspecified Adult Solid Tumor, Protocol Specific. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT00992303 currently recruiting?
Yes, NCT00992303 is actively recruiting participants. Contact the research team at suprabha.pulipparacharuvil@utsouthwestern.edu for enrollment information.
Where is the NCT00992303 trial being conducted?
This trial is being conducted at Dallas, United States.
Who is sponsoring the NCT00992303 clinical trial?
NCT00992303 is sponsored by University of Texas Southwestern Medical Center. The principal investigator is Robert Timmerman, MD at University of Texas Southwestern Medical Center - Dallas. The trial plans to enroll 10,000 participants.